Benzocaine (topical): Difference between revisions
No edit summary |
No edit summary |
||
| Line 145: | Line 145: | ||
<!--Look-Alike Drug Names--> | <!--Look-Alike Drug Names--> | ||
|drugShortage= | |drugShortage= | ||
}} | }} | ||
<!--Label Display Image--> | <!--Label Display Image--> | ||
| Line 157: | Line 150: | ||
[[Category:Drug]] | [[Category:Drug]] | ||
[[Category:Local anesthetics]] | |||
[[Category:Benzoates]] | |||
[[Category:Wyeth]] | |||
Revision as of 15:17, 13 May 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Benzocaine (topical) is a local anesthetic that is FDA approved for the treatment of dental pain. Common adverse reactions include contact dermatitis.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- For oral mucosal use only as directed by a dentist.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Benzocaine (topical) in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzocaine (topical) in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Benzocaine (topical) in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Benzocaine (topical) in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzocaine (topical) in pediatric patients.
Contraindications
There is limited information regarding Benzocaine (topical) Contraindications in the drug label.
Warnings
There is limited information regarding Benzocaine (topical) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Benzocaine (topical) in the drug label.
Postmarketing Experience
contact dermatitis, methemoglobinemia (rare)
Drug Interactions
There is limited information regarding Benzocaine (topical) Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Benzocaine (topical) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Benzocaine (topical) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Benzocaine (topical) with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Benzocaine (topical) with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Benzocaine (topical) with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Benzocaine (topical) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Benzocaine (topical) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Benzocaine (topical) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Benzocaine (topical) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Benzocaine (topical) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Benzocaine (topical) in patients who are immunocompromised.
Administration and Monitoring
Administration
Monitoring
There is limited information regarding Monitoring of Benzocaine (topical) in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Benzocaine (topical) in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Benzocaine (topical) in the drug label.
Pharmacology
| |
| |
Benzocaine (topical)
| |
| Systematic (IUPAC) name | |
| Ethyl 4-aminobenzoate | |
| Identifiers | |
| CAS number | |
| ATC code | C05 D04AB04 (WHO), Template:ATCvet, N01BA05 (WHO), R02AD01 (WHO) |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox |
| Mol. mass | 165.189 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Topical |
Mechanism of Action
There is limited information regarding Benzocaine (topical) Mechanism of Action in the drug label.
Structure
There is limited information regarding Benzocaine (topical) Structure in the drug label.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Benzocaine (topical) in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Benzocaine (topical) in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Benzocaine (topical) in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Benzocaine (topical) in the drug label.
How Supplied
There is limited information regarding Benzocaine (topical) How Supplied in the drug label.
Storage
- Store at controlled room temperature 59-86°F (15-30°C).
Images
Drug Images
{{#ask: Page Name::Benzocaine (topical) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Benzocaine (topical) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Benzocaine (topical) in the drug label.
Precautions with Alcohol
- Alcohol-Benzocaine (topical) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- TOPICAL ANESTHETIC BANANA®[1]
Look-Alike Drug Names
There is limited information regarding Benzocaine (topical) Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.